Selected Posters and Abstracts
Saquinavir (Invirase) [PI]
[P46] A study on the performance of combination of Kaletra and saquinavir twice-daily regimen on a group of antiretroviral therapy experienced patients
Kaveh Manavi and others.
[P35] Saquinavir in double protease inhibitor regimens boosted with ritonavir (r) results of the AROMA-cohort: comparison of saquinavir/atazanavir/r versus saquinavir/lopinavir/r
Axel Baumgarten.
[P76] Ritonavir boosted saquinavir once daily an Indian experience
Satish Kadappa and others.
[P391] Switching to saquinavir 500mg-based regimens maintains antiretroviral efficacy
Tabitha Mahungu and others.
[P383] Pharmacokinetics (PK), safety, tolerability and efficacy of boosted saquinavir 500mg film coated tablets in a regimen of 1000/100mg bid plus 2 nucleoside analogues (NRTIs) in HIV+ pregnant women
MY Tung and others.
[P378] Placental transfer of lopinavir, saquinavir, and ritonavir
Katharina Weizsaecker and others.
[P373] Barriers to the development of a pediatric formulation of saquinavir
Maria Bachynsky and others.
[P58] The Rainbow Cohort: successful initiation/switch with/from the new saquinavir 500mg formulation first results from Germany
H Knechten and others.
[P293] Effect of boosted saquinavir on the pharmacokinetics and pharmacodynamics of racemic methadone in opiate-dependent patients on stable methadone maintenance therapy
C Jamois and others.
[PL2.5] Saquinavir/r (SQV/r) BID vs lopinavir/r (LPV/r) BID plus emtricitabine/tenofovir (FTC/TDF) QD in ARV-naive HIV-1 infected patients: GEMINI Study
J Slim and others.
P271] Trough concentrations in HIV patients receiving boosted hard-gel capsules (HGC) and 500mg film-coated tablet (FCT) formulations of saquinavir
L Dickinson and others.

 

<— Conference Main Page

Conference
Main Page


FDA-Approved
HIV and AIDS Treatments

Protease Inhibitors
Agenerase
Aptivus
Crixivan
Fortovase
Invirase
Kaletra
Lexiva

Norvir
Prezista

Reyataz
Viracept


Nucleoside / Nucleotide Reverse Transcriptase Inhibitors

Combivir
Epivir
Emtriva
Epzicom
Hivid
Retrovir
Trizivir
Truvada  
Videx
Viread
Zerit
Ziagen


non Nucleoside Reverse Transcriptase Inhibitors
Rescriptor

Sustiva
Viramune

Entry Inhibitors
Fuzeon

Fixed-dose Combinations
Atripla
Combivir
Trizivir
Truvada